SonALAsense

Biotech

Developer of an SDT device designed to turn glioblastoma multiforme patients into cancer survivors. The company’s non-invasive drug-device combination has the ability to open the blood-brain barrier and improve chemotherapeutic drug delivery, enabling patients to get proprietary non-invasive drug-device combination therapy.

Address:
2600 Tenth Street
Suite 435
Berkeley, CA 94710
Website:
www.sonalasense.com